Angela C. O'DOnnell

Angela C. O'DOnnell

Auto-generated profile, based on publicly available information

Angela C. O'DOnnell

Department of Molecular Biosciences, The University of Texas at Austin

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
LBLouis-Marie Bobay
Louis-Marie Bobay
AOAngela C. O’dOnnell
Angela C. O’dOnnell
HOHoward Ochman
Howard Ochman
The Betacoronaviruses comprise multiple subgenera whose members have been implicated in human disease. As with SARS, MERS and now SARS-CoV-2, the origin and emergence of new variants are often attributed to events of recombination that alter host tropism or disease severity. In most cases, recombination has been detected by searches for excessively similar genomic regions in divergent strains; however, such analyses are complicated by the high mutation rates of RNA viruses, which can produce sequence similarities in distant strains by convergent mutations. By applying a genome-wide approach that examines the source of individual polymorphisms and that can be tested against null models in which recombination is absent and homoplasies can arise only by convergent mutations, we examine the extent and limits of recombination in Betacoronaviruses. We find that recombination accounts for nearly 40% of the polymorphisms circulating in populations and that gene exchange occurs almost exclusively among strains belonging to the same subgenus. Although experimental studies have shown that recombinational exchanges occur at random along the coronaviral genome, in nature, they are vastly overrepresented in regions controlling viral interaction with host cells.

8 April 2021 in Journal of General Virology
Verified
Journal Article
Open access
YLYiyuan Li
Yiyuan Li
AOAngela C. O’donnell
Angela C. O’donnell
HOHoward Ochman
Howard Ochman
Mosquito-borne arboviruses, including a diverse array of alphaviruses and flaviviruses, lead to hundreds of millions of human infections each year. Current methods for species-level classification of arboviruses adhere to guidelines prescribed by the International Committee on Taxonomy of Viruses (ICTV), and generally apply a polyphasic approach that might include information about viral vectors, hosts, geographical distribution, antigenicity, levels of DNA similarity, disease association and/or ecological characteristics. However, there is substantial variation in the criteria used to define viral species, which can lead to the establishment of artificial boundaries between species and inconsistencies when inferring their relatedness, variation and evolutionary history. In this study, we apply a single, uniform principle – that underlying the Biological Species Concept (BSC) – to define biological species of arboviruses based on recombination between genomes. Given that few recombination events have been documented in arboviruses, we investigate the incidence of recombination within and among major arboviral groups using an approach based on the ratio of homoplastic sites (recombinant alleles) to non-homoplastic sites (vertically transmitted alleles). This approach supports many ICTV-designations but also recognizes several cases in which a named species comprises multiple biological species. These findings demonstrate that this metric may be applied to all lifeforms, including viruses, and lead to more consistent and accurate delineation of viral species.

3 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AOAngela C. O’dOnnell
Angela C. O’dOnnell
XWXun Wang
Xun Wang
NKNikol Kadeřábková
Nikol Kadeřábková
KGKyra E. Groover
Kyra E. Groover
BPBethany C. Perez
Bethany C. Perez
BDBryan Davies
Bryan Davies
Nanobodies have been pursued as candidates for antimicrobial design due to their small size and versatile binding capacities, but direct antibacterial activity of a nanobody has yet to be described. Here, we employed a bacterial surface display platform to screen a synthetic library of nanobody variants for antimicrobial potential. We identified a candidate that binds the essential lipid A component of gram-negative lipopolysaccharide. Nonetheless, this nanobody required a weakened outer membrane to access its target and elicit its toxic activity. Borrowing from observations of innate immune proteins, we found that resurfacing nanobodies with positively charged residues enabled them to bind and perturb the gram-negative outer membrane, but this alone was not sufficient for toxic activity. However, when we resurface our lipid A-targeting nanobody, it gained the ability to disrupt the outer membrane and enact its antibacterial function against wild-type bacteria. This development of a dual-function nanobody that can reach and bind previously inaccessible gram-negative targets introduces a route for antimicrobial biologic advancement.

10 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SMStavros A. Maurakis
Stavros A. Maurakis
AOAngela C. O’DOnnell
Angela C. O’DOnnell
IBIstvan Botos
Istvan Botos
RGRodolfo Ghirlando
Rodolfo Ghirlando
BDBryan Davies
Bryan Davies
SBSusan K Buchanan
Susan K Buchanan
Drug-resistant bacterial infections have become a high-priority concern in the global healthcare landscape. Novel treatments for such infections are needed, but can be especially difficult to develop for Gram-negative species owing to the need to traverse the outer membrane to reach targets beneath. A promising solution is found in natural antibiotics such as albomycin, which can bind outer membrane siderophore receptors and co-opt them for import into the periplasm. Exploring this and similar mechanisms may open avenues for antibiotic development. An underappreciated class of natural antibiotics are the microcins, which are small antimicrobial proteins secreted by certain bacterial species as a means of inter-species competition. Once secreted, the microcins bind specific outer-membrane receptors of prey species and cross into the periplasm. Microcins have potent activity, bind specific targets, and have been shown to control pathobiont expansion and pathogen colonization in animal models. One such microcin, MccV, has previously been shown to utilize the E. coli colicin Ia receptor, Cir, for periplasmic import. Here, we report the first high-resolution structure of the Cir/MccV complex by Cryo-EM, revealing an interaction centered on an electropositive cavity within a usually occluded binding pocket in Cir. We also report the calculated affinity of MccV for Cir. We mutagenized putative interacting residues at this interface and identified key contacts that are critical to MccV binding and Cir-mediated import and bacteriolysis. Future efforts in this project will help us better understand the mechanisms of microcin killing, and will assess relationships between other microcins and their respective importers with the aim of understanding the potential for microcins to be used as treatment for drug-resistant pathogens.

22 April 2026 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
JPJennifer K. Parker
Jennifer K. Parker
LTLeon P. Toursarkissian
Leon P. Toursarkissian
JCJoanna R. Chang
Joanna R. Chang
SSSimon Sanchez-Paiva
Simon Sanchez-Paiva
AOAngela C. O'DOnnell
Angela C. O'DOnnell
BDBryan Davies
Bryan Davies
Serratia marcescens is a highly environmentally adaptable gram-negative bacterium which can be found in both free-living and host-associated lifestyles, where it can function as either a commensal or a pathogen. The diverse array of secreted factors produced by S. marcescens is suggested to facilitate this adaptability. Here, we describe and validate a class of secreted bacteriocins, called class II microcins, which have not previously been described in S. marcescens . Putative class II microcins are found in the majority (96%) of genomes analyzed here, including representative strains from numerous diverse lifestyles. The type of microcin in a given genome has some correspondence to the isolation source of its S. marcescens strain of origin. We demonstrate that heterologous secretion of these microcins can be used to validate their antibacterial activity, yielding 17 confirmed class II microcins from S. marcescens . Testing against a panel of S. marcescens , consisting predominantly of strains pathogenic to humans or insects, shows S. marcescens microcin activity ranges from narrow to broad spectrum. Identifying class II microcins and other factors which may contribute to interbacterial competition or colonization by S. marcescens could inform strategies to prevent S. marcescens infections. IMPORTANCE: Serratia marcescens is an abundant bacterium in many different environments, but it also represents an important opportunistic pathogen of humans and other animals. Our finding that S. marcescens encodes numerous antibacterial class II microcins is important to understanding factors that may contribute to the lifestyle versatility of this bacterium. Interfering with factors that promote competition or colonization could aid infection prevention.